Home » Stocks » MDT

Medtronic plc. (MDT)

Stock Price: $116.81 USD 0.00 (0.00%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
After-hours: $117.04 +0.23 (0.20%) Jan 15, 7:54 PM
Market Cap 157.23B
Revenue (ttm) 27.87B
Net Income (ttm) 3.54B
Shares Out 1.34B
EPS (ttm) 2.74
PE Ratio 42.63
Forward PE 20.58
Dividend $2.32
Dividend Yield 1.99%
Trading Day January 15
Last Price $116.81
Previous Close $116.81
Change ($) 0.00
Change (%) 0.00%
Day's Open 117.60
Day's Range 116.59 - 118.30
Day's Volume 5,659,503
52-Week Range 71.23 - 119.71

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 4 days ago

ADAPT-PD Global Study Designed to Demonstrate Safety & Efficacy of Automated Therapy Which Responds to Brain Signals in Parkinson's Disease Patients DUBLIN, Jan. 14, 2021 /PRNewswire/ -- Medtr...

CNBC Television - 1 week ago

Medtronic CEO says edge computing is helping to personalize medicine

Medtronic CEO Geoff Martha explained how new technologies are helping to improve therapies for treating neurodegenerative diseases, like Parkinson's disease.

Seeking Alpha - 1 week ago

Medtronic plc (MDT) CEO Geoff Martha Presents at 39th Annual JPMorgan Healthcare Conference (Transcript)

The Motley Fool - 1 week ago

They didn't all struggle in 2020, but they will definitely all thrive if the economy bounces back this year.

Other stocks mentioned: AAPL, DAL
Zacks Investment Research - 1 week ago

Investors continue to be optimistic about Medtronic (MDT) on slew of product launches and regulatory approvals.

PRNewsWire - 2 weeks ago

DUBLIN, Jan. 4, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the 39th Annual J.P. Morgan Healthcare ...

Seeking Alpha - 2 weeks ago

I analyzed lately both Abbott Laboratories and Owens & Minor. While Abbott is a dividend aristocrat, Owens & Minor is a speculative buy.

Zacks Investment Research - 2 weeks ago

Medtronic (MDT) expects fiscal third-quarter MITG growth to be in the low single digits.

Zacks Investment Research - 3 weeks ago

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?

The Motley Fool - 3 weeks ago

Intuitive Surgical and Medtronic are involved in robotic-assisted surgery (RAS) systems, but Intuitive's shares have soared compared to the gains enjoyed by Medtronic's stock.

Other stocks mentioned: ISRG
Schaeffers Research - 3 weeks ago

The shares of Medtronic PLC (NYSE:MDT) are up 0.3% at $114.74 at last check, after J.P.

Zacks Investment Research - 3 weeks ago

With the approval, Medtronic (MDT) aims to strengthen its Cardiac and Vascular Group business globally.

Forbes - 1 month ago

We think that 3M currently is a better pick compared to Medtronic. 3M trades at about 3.1x trailing Revenues, compared to over 5.4x for Medtronic, though both belong to different industry groups.

Other stocks mentioned: MMM
Zacks Investment Research - 1 month ago

Medtronic's (MDT) OsteoCool RFA System is expected to provide better relief from debilitating pain for cancer patients.

Benzinga - 1 month ago

Medtronic PLC (NYSE: MDT) is well-positioned for a COVID-19 recovery and has upside to the consensus estimates for fiscal 2022, according to Morgan Stanley. The Medtronic Analyst: David Lewis ...

24/7 Wall Street - 1 month ago

With 2020 rapidly and thankfully coming to a close, many investors are evaluating portfolios for 2021.

Other stocks mentioned: AES, AVGO, BMY, GS
PRNewsWire - 1 month ago

DUBLIN, Dec. 15, 2020 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced the release of outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation (RFA) Syst...

PRNewsWire - 1 month ago

DUBLIN, Dec. 14, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT) announced today that Sean Salmon, Executive Vice President and President, Diabetes Operating Unit has been named Executive Vice P...

Seeking Alpha - 1 month ago

Medtronic plc (MDT) 2020 Annual Meeting Conference (Transcript)

Zacks Investment Research - 1 month ago

Medtronic's (MDT) Carpediem CRRT system compares favorably with the traditional three times a week therapy session.

GuruFocus - 1 month ago

Last month, the stock market responded positively to the news of a potential Covid-19 vaccine. While the initial impact of the news appears to be dissipating, now may be the right time to look...

Other stocks mentioned: CARR, TT, ABT, BSX
Seeking Alpha - 1 month ago

This article is part of our monthly series where we highlight five companies that are large cap, relatively safe, dividend paying, and are offering large discounts to their historical norms. I...

Other stocks mentioned: GD, MO, NEE, TSN
GuruFocus - 1 month ago

Glenview Capital Management recently disclosed its portfolio updates for the third quarter of 2020, which ended on Sept. 30.

Other stocks mentioned: AMGN, PEAK
Seeking Alpha - 1 month ago

Medtronic's (MDT) Management Presents at Piper Sandler 32nd Annual Virtual Healthcare Conference (Transcript)

PRNewsWire - 1 month ago

DUBLIN, Dec. 1, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Evercore ISI 3rd Annual HealthCONx ...

Zacks Investment Research - 1 month ago

Among several domains within the MedTech space, several pediatric medical device stocks have been gaining traction amid the coronavirus pandemic

Other stocks mentioned: ABT, ALGN
Forbes - 1 month ago

We believe that Medtronic stock is a good buying opportunity at the present time. MDT stock trades near $115 currently and it is, in fact, down 6% from its pre-Covid high of $121 in February 2...

PRNewsWire - 1 month ago

DUBLIN, Nov. 30, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Piper Sandler 32nd Annual Healthca...

PRNewsWire - 1 month ago

DUBLIN and MINNEAPOLIS, Nov. 30, 2020 /PRNewswire/ -- With the pandemic surging across the globe and food insecurity on the rise, Medtronic and the Medtronic Foundation today announced an addi...

Zacks Investment Research - 1 month ago

Based on the ongoing strong recovery in sales, Medtronic (MDT) expects fiscal third-quarter MITG growth to be in the low single digits.

GuruFocus - 1 month ago

The S&P 500 saw its trailing 12-month real earnings per share (EPS) grow by approximately 1.4% on average every year over the past five years. The index's share price ($3,629.65 as of Wednesda...

Other stocks mentioned: MA, TMO
Bloomberg Markets and Finance - 1 month ago

Medtronic CEO on Second Quarter, New Therapies, Covid Impact

Nov.24 -- Medtronic Chief Executive Officer Geoff Martha discusses second-quarter results, new products and therapies, and efforts to return patients to the healthcare system amid the Covid-19...

Seeking Alpha - 1 month ago

Medtronic PLC's (MDT) CEO Geoffrey Martha on Q2 2021 Results - Earnings Call Transcript

Zacks Investment Research - 1 month ago

Deferred procedures due to the pandemic impact Medtronic's (MDT) Q2 performance.

CNBC Television - 1 month ago

Medtronic CEO Geoff Martha on earnings and how Covid is impacting business

Medtronic released its quarterly earning results that exceeded what analysts had been expecting. Ventilator sales were strong, but profits fell on weaker demand for medical devices as elective...

Benzinga - 1 month ago

Shares of Medtronic (NYSE:MDT) rose 0.2% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 22.14% over the past year to $1.02, which b...

Zacks Investment Research - 1 month ago

Medtronic (MDT) delivered earnings and revenue surprises of 30.77% and 8.51%, respectively, for the quarter ended October 2020. Do the numbers hold clues to what lies ahead for the stock?

Investors Business Daily - 1 month ago

Medtronic earnings and sales beat fiscal Q2 estimates. Shares of the medical products giant rose slightly, near a prior buy point.

PRNewsWire - 1 month ago

- Q2 Revenue of $7.6 Billion Decreased 0.8% Reported and 1.5% Organic - Q2 GAAP Diluted EPS of $0.36; Q2 Non-GAAP Diluted EPS of $1.02 DUBLIN, Nov. 24, 2020 /PRNewswire/ -- Medtronic plc (NYSE...

Forbes - 1 month ago

Medtronic is scheduled to report its fiscal Q2 2021 results on Tuesday, November 24. We expect Medtronic to likely beat the revenue and earnings expectations, driven by improved demand for med...

Zacks Investment Research - 1 month ago

Medtronic (MDT) is hopeful about a sequential improvement of about 8% in the fiscal second quarter, which implies a 9% year-over-year decline.

The Motley Fool - 2 months ago

Biotech stocks simply can't match these reliable returns.

Other stocks mentioned: DXCM, ABMD
Zacks Investment Research - 2 months ago

Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 2 months ago

Medtronic (MDT) expects Medicrea's capabilities and solutions to complement its fully-integrated procedural solution for surgical planning and delivery.

PRNewsWire - 2 months ago

DUBLIN, Nov. 16, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the primary results of the Medtronic-sponsored STOP AF First clini...

PRNewsWire - 2 months ago

DUBLIN, Nov. 16, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has completed its friendly tender offer for France-based Medicr...

The Motley Fool - 2 months ago

This device maker is riding the rising tide of continuous glucose monitoring systems.

PRNewsWire - 2 months ago

DUBLIN, Nov. 13, 2020 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced that it has been recognized as one of the world's leading companies fo...

Zacks Investment Research - 2 months ago

Medtronic's (MDT) strategic acquisition of Companion Medical strengthens the company's data science and AI capabilities.

Seeking Alpha - 2 months ago

Medtronic is a Dividend Champion with 43 consecutive years of dividend growth.  Shares currently yield 2.24%. Medtronic is a leader in the med-tech space with over 70 years of expertise in pus...

About MDT

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX... [Read more...]

Industry
Medical Devices
Founded
1949
CEO
Geoffrey Martha
Employees
90,000
Stock Exchange
NYSE
Ticker Symbol
MDT
Full Company Profile

Financial Performance

In 2020, Medtronic's revenue was $28.91 billion, a decrease of -5.38% compared to the previous year's $30.56 billion. Earnings were $4.79 billion, an increase of 3.41%.

Financial Statements

Analyst Forecasts

According to 27 analysts, the average rating for Medtronic stock is "Buy." The 12-month stock price forecast is 129.29, which is an increase of 10.68% from the latest price.

Price Target
$129.29
(10.68% upside)
Analyst Consensus: Buy